Moderna’s Suit Against Pfizer Could Result In ‘Modest Royalties’ Paid By Both Rivals

Moderna seeks damages for sales of Comirnaty in US and other wealthy countries from 8 March onward, a timeframe driven by Moderna's accessibility pledge. Suit claims Pfizer and BioNTech copied two key features of its mRNA technology for their rival COVID vaccine.